PTC THERAPEUTICS, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/49d6cc59-7421-4bdf-a4a2-6508343e0f6f/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.7B | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-017575 |
| FY 2024 | $806.8M | 2024-01-01 – 2024-12-31 | evidence 0001070081-25-000012 |
| FY 2023 | $937.8M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002196 |
| FY 2022 | $698.8M | 2022-01-01 – 2022-12-31 | evidence 0001070081-23-000011 |
| FY 2021 | $538.6M | 2021-01-01 – 2021-12-31 | evidence 0001070081-22-000011 |
| FY 2020 | $380.8M | 2020-01-01 – 2020-12-31 | evidence 0001070081-21-000009 |
| FY 2019 | $307.0M | 2019-01-01 – 2019-12-31 | evidence 0001070081-21-000009 |
| FY 2018 | $264.7M | 2018-01-01 – 2018-12-31 | evidence 0001070081-21-000009 |
| FY 2017 | $194.4M | 2017-01-01 – 2017-12-31 | evidence 0001070081-19-000018 |
| FY 2016 | $82.7M | 2016-01-01 – 2016-12-31 | evidence 0001070081-19-000018 |
| FY 2015 | $36.8M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010589 |
| FY 2014 | $25.2M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001457 |
| FY 2013 | $34.7M | 2013-01-01 – 2013-12-31 | evidence 0001047469-15-001457 |
| FY 2012 | $33.9M | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-001457 |
| FY 2011 | $105.4M | 2011-01-01 – 2011-12-31 | evidence 0001047469-14-001914 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PTC THERAPEUTICS, INC. — all facts · Net Income · Operating Income